Showing all 3 results
Glibenclamide & Metformin Hydrochloride Tablets
FreeProduct Composition & Standard Strengths
We supply this product in standardized Fixed-Dose Combinations (FDCs) designed for flexible clinical titration.
Active Ingredient Standard Strengths (per Tablet) Primary Clinical Function Metformin HCl 400 mg / 500 mg The Foundation: Reduces glucose production. Glibenclamide (Glyburide) 2.5 mg / 5 mg The Stimulator: Enhances insulin secretion. Excipients Pharma Grade The Matrix: Ensures stability of the FDC. Teneligliptin & Metformin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Bilayer or Matrix Sustained-Release Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of the highly hygroscopic Metformin component.
Active Ingredient Strength Primary Clinical Function Teneligliptin Hydrobromide Hydrate INN 20 mg Immediate-release DPP-4 inhibition for rapid post-prandial (after-meal) glucose control. Metformin Hydrochloride BP/Ph.Eur. 500 mg (Sustained-Release) Continuous 24-hour hepatic glucose suppression and peripheral insulin sensitization. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Magnesium Stearate SR Polymer Matrix / Diluent / Lubricant (Engineered for strict 24-hour kinetic release of Metformin) Teneligliptin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of the active pharmaceutical ingredient across diverse tropical and high-humidity climates.
Active Ingredient Strength Primary Clinical Use Teneligliptin Hydrobromide Hydrate INN 20 mg Standard Global Dose: Once-daily therapy for glycemic control in Type 2 Diabetes. Excipients Microcrystalline Cellulose / Mannitol / Croscarmellose Sodium / Magnesium Stearate Diluent / Superdisintegrant (Engineered for immediate gastric dissolution and rapid absorption)
